# Corza Medical to sell Biosurgery unit to EQT

GTCR announced that Corza Medical signed an agreement to sell its Biosurgery business unit, including the TachoSil surgical sealant patch portfolio, to private equity firm EQT. Financial terms were not disclosed.

- Type: Acquisition
- Announced: 2026-07-07
- Where: United States
- Status: announced
- Products: TachoSil surgical sealant patch
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [EQT](https://endata.com/companies/3219.md) (acquirer)
- [GTCR](https://endata.com/companies/8467.md) (investor)
- [Corza Medical](https://endata.com/companies/52955.md) (target)

## Sources

- [massdevice.com](https://www.massdevice.com/gtcr-divest-biosurgery-unit-corza-medical/), 2026-07-07: "Today's announcement marks an important milestone for Corza Medical."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.